AAFA

AAFA
38 BEITRÄGE 0 KOMMENTARE
The Asthma and Allergy Foundation of America (AAFA), a not-for-profit organization founded in 1953, is the leading patient organization for people with asthma and allergies, and the oldest asthma and allergy patient group in the world.
AAFA

CERTIFIED Baby Mattress Creates a Healthier Environment for Infants With Asthma and Allergies

Pure Zees recently announced the expansion of its innovative asthma & allergy friendly® mattresses into the U.S. market, unveiling a new U.S. website to...
AAFA

February Advocacy Update: Over-the-Counter Medicines, Restaurant Safety and Cleaner Cars

Welcome to your February advocacy update. I’m Jenna Riemenschneider, director of Advocacy at the Asthma and Allergy Foundation of America (AAFA). I am pictured...
AAFA

Clean Economy Act Would Benefit Millions of People With Asthma and Allergies by Addressing...

U.S. Senator Tom Carper (D-Del.), top Democrat on the U.S. Senate Environment and Public Works Committee, was joined by 32 Senators in introducing legislation...
AAFA

Coronavirus (2019-nCoV): What People With Asthma Need to Know

The 2019 new coronavirus (also known at 2019-nCoV) is a hot topic in the news. Now that it has spread to the U.S., you...
AAFA

Skip Flowers, Perfume and Candy for Your Valentine With Asthma and Allergies

Flowers, candy, perfume and candles may be common gifts for Valentine’s Day. But if you give them to your loved ones with asthma and...
AAFA

FDA Considers Biologic Dupilumab for Children Ages 6 to 11 Years With Moderate-to-Severe Atopic...

Regeneron Pharmaceuticals, Inc. and Sanofi today announced that the U.S. Food and Drug Administration (FDA) has accepted for Priority Review the supplemental Biologics License...
AAFA

DOT Proposes New Rules for Animals on Planes

On Jan. 22, 2020, the U.S. Department of Transportation (DOT) released proposed rules on animals on planes. If they finalize these rules, airlines would...
AAFA

Dr. Philip Norman: An AAFA Tribute to an Allergy Legend

If you’ve ever benefited from immunotherapy (allergy shots, SLIT or oral immunotherapy), you can thank Dr. Philip Sidney Norman. Dr. Norman put allergy research...
AAFA

AAFA CEO and President Testifies in Support of Protections for School Children With Asthma...

On Jan. 8, 2020, Kenneth Mendez, CEO and president of the Asthma and Allergy Foundation of America (AAFA), spoke before members of the U.S....
AAFA

Help Shape the Future of Asthma Treatment

Share your thoughts on the future of asthma treatment. Take two short surveys by Jan. 12, 2020, 11:59 p.m. ET, and we'll submit your...
AAFA

We Fight, Support and Advocate in Honor of Those Who Have Lost Their Lives

Dear Friends, One of the hardest things we do at the Asthma and Allergy Foundation of America is have conversations with families who have...
AAFA

Advances in Asthma and Allergies in 2019

These are just a few things we were able to do this year for the asthma and allergy community because of you. But there...
AAFA

Congress Expected to Approve Funding That Benefits People With Asthma and Allergies

On Dec. 16, 2019, Congress released a spending package to fund the government for 2020. This plan includes some big wins for the asthma...
AAFA

LUSTER Clinical Trial Results for People With Uncontrolled Moderate-to-Severe Asthma Announced

Novartis today announced topline results from its pivotal global Phase III LUSTER-11 and LUSTER-22 studies exploring the efficacy and safety of the investigational oral,...
AAFA

FDA Will Consider Xolair for the Treatment of Nasal Polyps

Genentech, a member of the Roche Group, announced that the U.S. Food and Drug Administration (FDA) has accepted the company’s supplemental Biologics License Application...
WERBUNG